Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65. 

Estenosis carotídea y TAVI

Even though TAVR has advanced in the treatment of this disease, many patients present carotid aortic stenosis (CAS), which involves additional surgical risk. This risk has not been thoroughly assessed in the context of TAVR. 

A meta-analysis was carried out including 5 observational studies with a total 111,915 patients. Mean patient age was 83 and 46% were women.

Stroke or transient ischemic attack (TIA) rate was higher in patients presenting CAS (OR 1.44; CI 95% 1.07–1.95; p = 0.016), with no significant differences in myocardial infarction (OR 1.24; CI 95% 1.05–1.47; p = 0.074), all-cause mortality (OR 0.99; CI 95% 0.71–1.37; p = 0.94), acute kidney failure (OR 0.98; CI 95% 0.90–1.06) and the need for pacemaker implantation after TAVR (OR 0.95; CI 95% 0.70–1.30; p = 0.759) between both groups.

Conclusión

This analysis revealed a link between carotid stenosis and cerebrovascular events in patients undergoing TAVR, with no significant impact on all-cause mortality. We highlight the need for prospective studies for a more detailed assessment of additional determinants of this association, such as unilateral or bilateral compromise and stenosis degree, which increases risk. 

Original Title: Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.

Reference: Lucas Caetano da Silva, et al. International Journal of Cardiology, https://doi.org/10.1016/j.ijcard.2023.131670.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....